FDA Inspection
The American National Red CrossThe American National Red Cross – FDA Inspection, Apr 8, 2026
Record Details
This FDA Inspection record concerns The American National Red Cross, with an inspection on April 8, 2026, issued by the New England District Office, covering biologics.
View Company Profile
ID · 167eb155-438f-4022-955e-79ef54b4a252
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1311374
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.40Clean & orderly
Full citation text and observation details available on the Dashboard.
Other FDA inspections of The American National Red Cross
8| Date | Classification | Office | Project area |
|---|---|---|---|
| October 28, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 28, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 12, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 3, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 26, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for The American National Red Cross
- FDA Inspection 1190330 - 2022-10-28
- FDA Inspection 1112311 - 2019-10-28
- FDA Inspection 1043598 - 2018-02-12
- FDA Inspection 973820 - 2016-06-03
- FDA Inspection 884313 - 2014-06-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.